Veracyte Historical Balance Sheet

VCYT Stock

USD 41.10 1.51 3.81%

Trend analysis of Veracyte balance sheet accounts such as Total Assets of 1.2 B, Other Current Liab of 37.9 M, Total Current Liabilities of 64.3 M or Total Stockholder Equity of 1.1 B provides information on Veracyte's total assets, liabilities, and equity, which is the actual value of Veracyte to its prevalent stockholders. By breaking down trends over time using Veracyte balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Veracyte latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Veracyte is a good buy for the upcoming year.

Veracyte Inventory

16.93 Million

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Veracyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Veracyte Stock please use our How to Invest in Veracyte guide.

About Veracyte Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Veracyte at a specified time, usually calculated after every quarter, six months, or one year. Veracyte Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Veracyte and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Veracyte currently owns. An asset can also be divided into two categories, current and non-current.

Veracyte Balance Sheet Chart

At this time, Veracyte's Net Receivables is comparatively stable compared to the past year. Common Stock Total Equity is likely to gain to about 86.9 K in 2024, despite the fact that Retained Earnings are likely to grow to (444.7 M).

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of Veracyte assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Veracyte books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Veracyte balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Veracyte are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most accounts from Veracyte's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Veracyte current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Veracyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Veracyte Stock please use our How to Invest in Veracyte guide.At this time, Veracyte's Net Receivables is comparatively stable compared to the past year. Common Stock Total Equity is likely to gain to about 86.9 K in 2024, despite the fact that Retained Earnings are likely to grow to (444.7 M).

	2021	2022	2023	2024 (projected)
Other Current Liabilities	38.8M	40.0M	36.1M	37.9M
Total Assets	1.2B	1.2B	1.1B	1.2B

Other Current Liab Total Assets

Veracyte balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Property Plant Equipment
Total Assets		0.98	0.98	1.0	0.76	0.96	-0.68	-0.88	0.9	0.61	0.98	-0.49	0.31	0.63	0.97	0.9	0.85	0.28	0.95	0.97	0.99	0.84	0.88	0.73	0.81	0.96
Other Current Liab	0.98		1.0	0.97	0.74	0.95	-0.57	-0.85	0.95	0.5	0.98	-0.51	0.2	0.53	0.96	0.89	0.81	0.31	0.96	0.97	0.96	0.87	0.87	0.64	0.8	0.97
Total Current Liabilities	0.98	1.0		0.98	0.73	0.94	-0.57	-0.85	0.96	0.5	0.99	-0.49	0.18	0.53	0.95	0.88	0.8	0.28	0.96	0.97	0.97	0.85	0.88	0.64	0.78	0.97
Total Stockholder Equity	1.0	0.97	0.98		0.75	0.96	-0.68	-0.87	0.9	0.61	0.98	-0.48	0.3	0.63	0.97	0.89	0.84	0.26	0.94	0.97	0.99	0.83	0.88	0.73	0.8	0.96
Other Liab	0.76	0.74	0.73	0.75		0.81	-0.7	-0.73	0.61	0.74	0.7	-0.55	0.5	0.74	0.78	0.77	0.84	0.53	0.66	0.78	0.76	0.86	0.56	0.81	0.84	0.71
Property Plant And Equipment Net	0.96	0.95	0.94	0.96	0.81		-0.71	-0.94	0.85	0.66	0.93	-0.42	0.34	0.68	0.98	0.96	0.9	0.44	0.96	0.93	0.98	0.87	0.88	0.77	0.88	0.96
Net Debt	-0.68	-0.57	-0.57	-0.68	-0.7	-0.71		0.69	-0.48	-0.97	-0.53	0.1	-0.7	-0.97	-0.67	-0.77	-0.71	-0.25	-0.61	-0.56	-0.69	-0.52	-0.57	-0.94	-0.74	-0.56
Retained Earnings	-0.88	-0.85	-0.85	-0.87	-0.73	-0.94	0.69		-0.75	-0.65	-0.83	0.25	-0.34	-0.67	-0.94	-0.95	-0.92	-0.5	-0.91	-0.83	-0.94	-0.82	-0.86	-0.75	-0.87	-0.91
Accounts Payable	0.9	0.95	0.96	0.9	0.61	0.85	-0.48	-0.75		0.4	0.92	-0.41	0.07	0.42	0.85	0.82	0.68	0.19	0.92	0.91	0.89	0.78	0.85	0.52	0.7	0.91
Cash	0.61	0.5	0.5	0.61	0.74	0.66	-0.97	-0.65	0.4		0.46	-0.17	0.77	1.0	0.63	0.73	0.75	0.33	0.53	0.5	0.63	0.57	0.45	0.98	0.79	0.49
Non Current Assets Total	0.98	0.98	0.99	0.98	0.7	0.93	-0.53	-0.83	0.92	0.46		-0.54	0.18	0.49	0.95	0.83	0.79	0.23	0.93	0.98	0.96	0.83	0.86	0.61	0.74	0.96
Non Currrent Assets Other	-0.49	-0.51	-0.49	-0.48	-0.55	-0.42	0.1	0.25	-0.41	-0.17	-0.54		-0.38	-0.2	-0.46	-0.27	-0.48	-0.29	-0.28	-0.56	-0.42	-0.64	-0.06	-0.3	-0.44	-0.37
Other Assets	0.31	0.2	0.18	0.3	0.5	0.34	-0.7	-0.34	0.07	0.77	0.18	-0.38		0.79	0.34	0.38	0.53	0.33	0.16	0.18	0.32	0.36	-0.03	0.75	0.54	0.14
Cash And Short Term Investments	0.63	0.53	0.53	0.63	0.74	0.68	-0.97	-0.67	0.42	1.0	0.49	-0.2	0.79		0.65	0.74	0.77	0.33	0.55	0.52	0.65	0.59	0.46	0.99	0.81	0.51
Net Receivables	0.97	0.96	0.95	0.97	0.78	0.98	-0.67	-0.94	0.85	0.63	0.95	-0.46	0.34	0.65		0.95	0.9	0.44	0.96	0.94	0.99	0.89	0.87	0.75	0.87	0.96
Common Stock Total Equity	0.9	0.89	0.88	0.89	0.77	0.96	-0.77	-0.95	0.82	0.73	0.83	-0.27	0.38	0.74	0.95		0.88	0.52	0.93	0.85	0.94	0.85	0.86	0.81	0.92	0.91
Common Stock Shares Outstanding	0.85	0.81	0.8	0.84	0.84	0.9	-0.71	-0.92	0.68	0.75	0.79	-0.48	0.53	0.77	0.9	0.88		0.49	0.81	0.8	0.89	0.9	0.69	0.86	0.95	0.81
Non Current Liabilities Total	0.28	0.31	0.28	0.26	0.53	0.44	-0.25	-0.5	0.19	0.33	0.23	-0.29	0.33	0.33	0.44	0.52	0.49		0.32	0.33	0.35	0.62	0.2	0.37	0.59	0.36
Inventory	0.95	0.96	0.96	0.94	0.66	0.96	-0.61	-0.91	0.92	0.53	0.93	-0.28	0.16	0.55	0.96	0.93	0.81	0.32		0.9	0.96	0.8	0.95	0.65	0.8	0.97
Other Current Assets	0.97	0.97	0.97	0.97	0.78	0.93	-0.56	-0.83	0.91	0.5	0.98	-0.56	0.18	0.52	0.94	0.85	0.8	0.33	0.9		0.95	0.86	0.85	0.63	0.76	0.95
Other Stockholder Equity	0.99	0.96	0.97	0.99	0.76	0.98	-0.69	-0.94	0.89	0.63	0.96	-0.42	0.32	0.65	0.99	0.94	0.89	0.35	0.96	0.95		0.85	0.9	0.75	0.84	0.97
Total Liab	0.84	0.87	0.85	0.83	0.86	0.87	-0.52	-0.82	0.78	0.57	0.83	-0.64	0.36	0.59	0.89	0.85	0.9	0.62	0.8	0.86	0.85		0.65	0.71	0.92	0.84
Property Plant And Equipment Gross	0.88	0.87	0.88	0.88	0.56	0.88	-0.57	-0.86	0.85	0.45	0.86	-0.06	-0.03	0.46	0.87	0.86	0.69	0.2	0.95	0.85	0.9	0.65		0.54	0.65	0.94
Total Current Assets	0.73	0.64	0.64	0.73	0.81	0.77	-0.94	-0.75	0.52	0.98	0.61	-0.3	0.75	0.99	0.75	0.81	0.86	0.37	0.65	0.63	0.75	0.71	0.54		0.88	0.62
Common Stock	0.81	0.8	0.78	0.8	0.84	0.88	-0.74	-0.87	0.7	0.79	0.74	-0.44	0.54	0.81	0.87	0.92	0.95	0.59	0.8	0.76	0.84	0.92	0.65	0.88		0.78
Property Plant Equipment	0.96	0.97	0.97	0.96	0.71	0.96	-0.56	-0.91	0.91	0.49	0.96	-0.37	0.14	0.51	0.96	0.91	0.81	0.36	0.97	0.95	0.97	0.84	0.94	0.62	0.78

Click cells to compare fundamentals

Veracyte Account Relationship Matchups

Veracyte balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	275.2M	457.2M	1.2B	1.2B	1.1B	1.2B
Other Current Liab	13.7M	10.1M	38.8M	40.0M	36.1M	37.9M
Total Current Liabilities	17.5M	16.8M	64.2M	62.6M	61.2M	64.3M
Total Stockholder Equity	239.5M	421.2M	1.1B	1.1B	1.0B	1.1B
Other Liab	6.1M	8.4M	13.1M	7.6M	8.7M	5.6M
Property Plant And Equipment Net	17.7M	16.8M	31.1M	30.9M	30.9M	32.4M
Net Debt	(145.7M)	(337.0M)	(154.3M)	(139.5M)	(203.8M)	(193.6M)
Retained Earnings	(246.7M)	(281.6M)	(357.2M)	(393.7M)	(468.1M)	(444.7M)
Accounts Payable	2.3M	3.1M	12.4M	11.9M	12.9M	13.6M
Cash	159.3M	349.4M	173.2M	154.2M	216.5M	117.7M
Non Current Assets Total	87.5M	81.5M	944.7M	907.8M	829.3M	870.7M
Non Currrent Assets Other	2.0M	2.0M	(35.1M)	(26.8M)	6.8M	7.2M
Other Assets	2.0M	9.8M	2.9M	6.2M	1.0	0.95
Cash And Short Term Investments	159.3M	349.4M	173.2M	178.9M	216.5M	119.7M
Net Receivables	19.3M	18.5M	41.5M	44.0M	40.4M	42.4M
Common Stock Total Equity	50K	58K	71K	72K	82.8K	86.9K
Common Stock Shares Outstanding	46.1M	53.2M	67.9M	71.5M	72.6M	41.6M
Liabilities And Stockholders Equity	275.2M	457.2M	1.2B	1.2B	1.1B	1.2B
Non Current Liabilities Total	18.3M	19.2M	27.2M	18.6M	9.6M	17.6M
Inventory	6.8M	4.7M	11.2M	14.3M	16.1M	16.9M
Other Current Assets	2.2M	3.2M	17.2M	11.5M	12.7M	13.3M
Other Stockholder Equity	486.1M	702.8M	1.5B	1.5B	1.5B	1.6B
Total Liab	35.8M	35.9M	91.3M	81.2M	70.8M	44.5M
Property Plant And Equipment Gross	17.7M	9.0M	31.1M	30.9M	63.7M	66.9M
Total Current Assets	187.7M	375.7M	243.1M	248.6M	285.6M	148.7M
Accumulated Other Comprehensive Income	(12.0M)	0.0	(15.1M)	(31.3M)	(24.0M)	(22.8M)
Common Stock	50K	58K	71K	72K	73K	42.9K
Property Plant Equipment	8.9M	9.0M	31.1M	30.9M	35.5M	37.3M
Short Long Term Debt Total	13.6M	12.3M	18.9M	14.7M	12.6M	16.8M
Net Tangible Assets	171.7M	358.6M	185.9M	379.3M	436.2M	458.0M
Long Term Debt	25.2M	23.9M	694K	810K	931.5K	884.9K
Retained Earnings Total Equity	(246.7M)	(281.6M)	(357.2M)	(393.7M)	(354.3M)	(372.1M)
Long Term Debt Total	25.2M	23.9M	694K	810K	931.5K	884.9K
Capital Surpluse	486.1M	702.8M	1.5B	1.5B	1.7B	1.8B
Deferred Long Term Liab	4.2M	3.9M	5.6M	4.5M	5.2M	4.3M
Intangible Assets	65.0M	59.9M	202.7M	174.9M	88.6M	66.2M
Short Term Debt	1.4M	3.2M	8.4M	8.1M	10.2M	7.5M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Veracyte Stock Analysis

When running Veracyte's price analysis, check to measure Veracyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veracyte is operating at the current time. Most of Veracyte's value examination focuses on studying past and present price action to predict the probability of Veracyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veracyte's price. Additionally, you may evaluate how the addition of Veracyte to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Veracyte Historical Balance Sheet

Veracyte Inventory

16.93 Million

About Veracyte Balance Sheet Analysis

Veracyte Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Veracyte balance sheet Correlations

Veracyte Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Veracyte balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Veracyte Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Total Current Liabilities	+ 1.0	Other Current Liab
Cash And Short Term Investments	+ 1.0	Cash
Other Stockholder Equity	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Total Current Liabilities
Other Stockholder Equity	+ 0.99	Total Stockholder Equity

Cash And Short Term Investments	- 0.97	Net Debt
Cash	- 0.97	Net Debt
Common Stock Total Equity	- 0.95	Retained Earnings
Other Stockholder Equity	- 0.94	Retained Earnings
Net Receivables	- 0.94	Retained Earnings
Total Current Assets	- 0.94	Net Debt